Neurotrope, Inc. (NTRP): New Bullish Coverage

NTRP – Roth Capital initiates as a buy, $15PT. This price target represents a 74.83% upside over the stock’s previous closing price of $8.58.


Update: As of Dec. 10, 2018, this bullish analyst call has returned -37.65%.


Key Facts Surrounding This News Item


  • NTRP had a POWR Rating of D (Sell) coming into today.
  • NTRP was -3.56% below its 10-Day Moving Average coming into today.
  • NTRP was -0.49% below its 20-Day Moving Average coming into today.
  • NTRP was 10.82% above its 50-Day Moving Average coming into today.
  • NTRP was 26.64% above its 100-Day Moving Average coming into today.
  • NTRP was 36.72% above its 200-Day Moving Average coming into today.
  • NTRP had returned +21.88% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Neurotrope, Inc. (NTRP)


Neurotrope, Inc., a biopharmaceutical company, focuses on developing therapeutic and diagnostic technologies in the field of neurodegenerative diseases in the United States. The company was founded in 2012 and is based in New York City, New York. View our full NTRP ticker page with ratings, news, and more.

NTRP at a Glance

NTRP Current POWR Rating™
Overall POWR Rating™
NTRP Current Price $5.35 0.93%
More NTRP Ratings, Data, and News

NTRP Price Reaction

The day of this event (Mar. 8, 2018)
NTRP Closing Price$9.00 4.90%
NTRP Volume29,700
64.86% from avg
Leading up to this event
NTRP 1-mo return5.02%
After this event
NTRP 1-day return4.56%
NTRP 3-day return3.70%
NTRP 5-day return3.13%

NTRP Price Chart


The Top Stocks For 2019

More Neurotrope, Inc. (NTRP) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All NTRP News
Page generated in 0.9429 seconds.